- Credit Suisse's 26th Annual Healthcare Conference on November 7 in Scottsdale, AZ
- Stifel 2017 Healthcare Conference on November 14 in New York
- Evercore ISI Biopharma Catalyst/Deep Dive Conference on November 29 in Boston
SAN RAFAEL, Calif., Oct. 31, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. BMRN today announced that management will participate in Credit Suisse's 26th Annual Healthcare Conference on November 7, 2017 at 9:10am MT/11:10am ET, in Scottsdale, Arizona, the Stifel 2017 Healthcare Conference on November 14, 2017 at 10:15am ET in New York and the Evercore ISI Biopharma Catalyst/Deep Dive Conference on November 29, 2017 at 11:00am ET in Boston. To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: | |
Investors |
Media |
Traci McCarty |
Debra Charlesworth |
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
(415) 455-7558 |
(415) 455-7451 |
View original content with multimedia:http://www.prnewswire.com/news-releases/biomarin-to-attend-three-upcoming-investor-conferences-300542649.html
SOURCE BioMarin Pharmaceutical Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.